X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3983) 3983
Publication (347) 347
Book / eBook (99) 99
Book Review (57) 57
Conference Proceeding (28) 28
Book Chapter (9) 9
Magazine Article (8) 8
Dissertation (3) 3
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2976) 2976
male (2165) 2165
cerebral hemorrhage - chemically induced (2019) 2019
female (1782) 1782
index medicus (1545) 1545
animals (1199) 1199
middle aged (1134) 1134
aged (1089) 1089
clinical neurology (1088) 1088
stroke (901) 901
adult (835) 835
neurosciences (754) 754
risk factors (672) 672
rats (665) 665
anticoagulants - adverse effects (548) 548
intracerebral hemorrhage (546) 546
treatment outcome (517) 517
peripheral vascular disease (495) 495
neurology (449) 449
aged, 80 and over (446) 446
time factors (438) 438
hemorrhage (426) 426
fibrinolytic agents - adverse effects (423) 423
brain (417) 417
stroke - drug therapy (417) 417
tissue plasminogen activator - adverse effects (415) 415
disease models, animal (403) 403
tomography, x-ray computed (373) 373
retrospective studies (329) 329
therapy (325) 325
rats, sprague-dawley (316) 316
thrombolytic therapy - adverse effects (313) 313
ischemia (309) 309
risk (307) 307
brain ischemia - drug therapy (300) 300
surgery (285) 285
magnetic resonance imaging (278) 278
thrombolysis (277) 277
cerebral hemorrhage - pathology (267) 267
hemorrhage - chemically induced (266) 266
mice (264) 264
medicine, general & internal (256) 256
fibrinolytic agents - therapeutic use (255) 255
anticoagulants - therapeutic use (253) 253
brain - pathology (250) 250
tissue plasminogen activator - therapeutic use (249) 249
warfarin (237) 237
dose-response relationship, drug (236) 236
cerebral hemorrhage - epidemiology (230) 230
platelet aggregation inhibitors - adverse effects (228) 228
pharmacology & pharmacy (225) 225
mortality (224) 224
warfarin - adverse effects (219) 219
analysis (212) 212
medicine & public health (212) 212
cerebral hemorrhage - diagnostic imaging (210) 210
thrombolytic therapy (210) 210
care and treatment (209) 209
acute ischemic-stroke (205) 205
tissue plasminogen activator - administration & dosage (204) 204
adolescent (199) 199
cerebral angiography (199) 199
infant, newborn (196) 196
intracranial hemorrhage (195) 195
fibrinolytic agents - administration & dosage (192) 192
pregnancy (191) 191
subarachnoid hemorrhage (191) 191
prospective studies (190) 190
anticoagulants (185) 185
cerebral infarction (185) 185
anticoagulants - administration & dosage (184) 184
abridged index medicus (182) 182
cerebral hemorrhage - diagnosis (182) 182
aspirin (181) 181
prevention (175) 175
research (175) 175
aspirin - adverse effects (174) 174
article (170) 170
cerebral hemorrhage - physiopathology (169) 169
health aspects (169) 169
acute disease (167) 167
risk assessment (166) 166
hematology (164) 164
brain - drug effects (163) 163
management (163) 163
cerebral hemorrhage - etiology (161) 161
drug therapy (160) 160
tissue-plasminogen activator (160) 160
cerebral-ischemia (156) 156
cerebral hemorrhage - complications (155) 155
cerebral hemorrhage - drug therapy (155) 155
cerebral hemorrhage - mortality (154) 154
follow-up studies (152) 152
cerebral hemorrhage - prevention & control (151) 151
drug therapy, combination (151) 151
focal cerebral-ischemia (146) 146
stroke - prevention & control (146) 146
stroke - etiology (143) 143
heparin - adverse effects (142) 142
platelet aggregation inhibitors - therapeutic use (140) 140
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (74) 74
Holland Bloorview Kids Rehabilitation - Stacks (6) 6
OISE - Stacks (6) 6
UTL at Downsview - May be requested (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Online Resources - Online (4) 4
Thomas Fisher Rare Book - Rare Book (4) 4
UofT at Mississauga - Stacks (4) 4
UofT at Scarborough - Stacks (4) 4
Baycrest Hospital - Stacks (2) 2
Robarts - Stacks (2) 2
West Park Healthcare Centre - Stacks (2) 2
Baycrest Hospital - Wellness Library (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Missing (1) 1
Law (Bora Laskin) - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3761) 3761
German (100) 100
French (77) 77
Spanish (58) 58
Japanese (35) 35
Swedish (17) 17
Chinese (11) 11
Dutch (10) 10
Russian (10) 10
Danish (8) 8
Italian (8) 8
Polish (6) 6
Norwegian (5) 5
Hungarian (2) 2
Finnish (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 02/2015, Volume 313, Issue 8, pp. 824 - 836
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10038, pp. 2605 - 2613
Journal Article
Stroke, ISSN 0039-2499, 06/2012, Volume 43, Issue 6, pp. 1524 - 1531
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 3, pp. 203 - 212
Adults with vascular disease were treated with a statin to lower LDL cholesterol and were assigned to receive either extended-release niacin plus laropiprant... 
NICOTINIC-ACID | LDL CHOLESTEROL | MEDICINE, GENERAL & INTERNAL | METABOLIC SYNDROME | MYOCARDIAL-INFARCTION | RANDOMIZED-TRIALS | EFFICACY | SAFETY | PLACEBO-CONTROLLED TRIAL | NIACIN/LAROPIPRANT | DYSLIPIDEMIA | Follow-Up Studies | Humans | Middle Aged | Male | Hypercholesterolemia - drug therapy | Indoles - administration & dosage | Infection - chemically induced | Niacin - administration & dosage | Treatment Failure | Musculoskeletal Diseases - chemically induced | Niacin - adverse effects | Cholesterol, LDL - blood | Female | Hypolipidemic Agents - adverse effects | Atherosclerosis - drug therapy | Double-Blind Method | Risk Factors | Indoles - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hypolipidemic Agents - administration & dosage | Diabetes Mellitus - chemically induced | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Drug Combinations | Dose-response relationship (Biochemistry) | Laropiprant | Blood circulation disorders | Care and treatment | Dosage and administration | Niacin | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Heart attacks | Risk groups | Diabetes mellitus | Cardiovascular disease | Low density lipoprotein | Cholesterol | Musculoskeletal system | Vascular diseases | Arteriosclerosis | Vitamin B | Skin | Lipoproteins (high density) | Drug dosages | Statins
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 2, pp. 136 - 148
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2012, Volume 366, Issue 1, pp. 9 - 19
Journal Article